Infectious Disease Alert (Vol. 36, No. 6) - March 1, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2017

Valid through: March 2020

Target Audience

This activity is intended for the infectious disease specialist.

Subjects

  • Vancomycin Combined with Piperacillin-Tazobactam Increases the Risk for Acute Kidney Injury
  • Inflammation in HIV Also Is Mediated by CD8+ T-cells and Platelets
  • Does Tonsillectomy Decrease Throat Infections?
  • Antibiotic Treatment in Community-acquired Pneumonia
  • Listeria Monocytogenes: Maternal-fetal Infection, Bacteremia, and Meningoencephalitis
  • Adult Immunizations — 2017 Changes

Objectives

  • Discuss the diagnosis of infectious diseases
  • Explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • Discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Credit Available

Physicians

  • Maximum of 3.0 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Faculty Listing

Authors

Stan Deresinski, MD, FACP, FIDSA, Clinical Professor of Medicine, Stanford University

Philip R. Fischer, MD, DTM&H, Professor of Pediatrics, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN

Dean Winslow, MD, Professor of Medicine, Division of General Medical Disciplines, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine

Richard R. Watkins, MD, MS, FACP, Division of Infectious Diseases, Akron General Medical Center, Akron, OH; Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH

Kathryn Radigan, MD, Attending Physician, Division of Pulmonary and Critical Care, Stroger Hospital of Cook County, Chicago

Carol Kemper, MD, FACP, Clinical Associate Professor of Medicine, Stanford University, Division of Infectious Diseases, Santa Clara Valley Medical Center

Editors

Physician Editor:

Stan Deresinski, MD, FACP, FIDSA

Clinical Professor of Medicine,
Stanford University.

AHC Media Executive Editor: Shelly Morrow Mark

Financial Disclosure

Infectious Disease Alert’s editor, Stan Deresinski, MD, FACP, FIDSA, peer reviewer Patrick Joseph, MD, Updates author, Carol A. Kemper, MD, FACP, peer reviewer Kiran Gajurel, MD, executive editor Shelly Morrow Mark, editor Jonathan Springston, AHC Media editorial group manager Terrey L. Hatcher, and senior accreditations officer Lee Landenberger report no financial relationships to this field of study.

Dr. Richard Watkins reports that he has received research support from Allergan. Dr. Philip Fischer, Dr. Dean Winslow, Dr. Kathryn Radigan report no financial relationships relevant to this field of study.

 

Copyright 2017, AHC Media. All rights reserved.